Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology

Pfaar O, Hamelmann E, Klimek L, Taube C, Vogelberg C, Wagenmann M, Werfel T, Worm M (2022)
Clinical and Translational Allergy 12(3): e12134.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Pfaar, Oliver; Hamelmann, EckardUniBi; Klimek, Ludger; Taube, Christian; Vogelberg, Christian; Wagenmann, Martin; Werfel, Thomas; Worm, Margitta
Abstract / Bemerkung
BACKGROUND: When the coronavirus pandemic 2019 (COVID-19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real-world data on the daily routine of administering subcutaneous AIT (SCIT) and sublingual AIT (SLIT) during the COVID-19 pandemic.; METHODS: A web-based retrospective survey using the online platform survio with 26 standardized questions was used to survey physicians treating allergic patients during the pandemic.; RESULTS: Three hundred and forty-five physicians who regularly offer and perform AIT in German-speaking countries responded to the questions. 70.4% of the respondents stated that they regularly initiated and dosed up SCIT for inhalant allergies (41.4% venom-SCIT, 73.6% SLIT), and 85.2% of the respondents stated that they continued SCIT for inhalant allergies during the maintenance phase in a regular way (59.1% venom-SCIT, 90.4% SLIT) in healthy patients without current symptoms indicating an infection with COVID-19. With regard to tolerability, there was no evidence for increased occurrence of adverse events in patients without current symptoms of COVID-19 infection during the pandemic.; CONCLUSIONS: This retrospective study demonstrated adherence to national and international position papers of AIT during the COVID-19 pandemic in German-speaking countries. Besides, the survey has confirmed a good tolerability of AIT for both SCIT and SLIT. © 2022 The Authors. Clinical and Translational Allergy published by John Wiley& Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
Erscheinungsjahr
2022
Zeitschriftentitel
Clinical and Translational Allergy
Band
12
Ausgabe
3
Art.-Nr.
e12134
eISSN
2045-7022
Page URI
https://pub.uni-bielefeld.de/record/2962338

Zitieren

Pfaar O, Hamelmann E, Klimek L, et al. Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology. Clinical and Translational Allergy. 2022;12(3): e12134.
Pfaar, O., Hamelmann, E., Klimek, L., Taube, C., Vogelberg, C., Wagenmann, M., Werfel, T., et al. (2022). Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology. Clinical and Translational Allergy, 12(3), e12134. https://doi.org/10.1002/clt2.12134
Pfaar, O., Hamelmann, E., Klimek, L., Taube, C., Vogelberg, C., Wagenmann, M., Werfel, T., and Worm, M. (2022). Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology. Clinical and Translational Allergy 12:e12134.
Pfaar, O., et al., 2022. Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology. Clinical and Translational Allergy, 12(3): e12134.
O. Pfaar, et al., “Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology”, Clinical and Translational Allergy, vol. 12, 2022, : e12134.
Pfaar, O., Hamelmann, E., Klimek, L., Taube, C., Vogelberg, C., Wagenmann, M., Werfel, T., Worm, M.: Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology. Clinical and Translational Allergy. 12, : e12134 (2022).
Pfaar, Oliver, Hamelmann, Eckard, Klimek, Ludger, Taube, Christian, Vogelberg, Christian, Wagenmann, Martin, Werfel, Thomas, and Worm, Margitta. “Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology”. Clinical and Translational Allergy 12.3 (2022): e12134.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 35344300
PubMed | Europe PMC

Suchen in

Google Scholar